透明质酸在肿瘤治疗药物新型给药系统中的应用  

Application of hyaluronic acid in the novel drug delivery system for cancer therapy

作　　者：邱丽筠[1] 黄丽丽[1] 俞淑文[1] 

机构地区：[1]山东大学附属济南市中心医院药学部,250013

出　　处：《中国实用医药》2014年第16期238-241,共4页China Practical Medicine

摘　　要：透明质酸(hyaluronic acid,HA)因其良好的理化性质和肿瘤靶向性,已作为药物载体或者靶向因子应用于肿瘤治疗的新型给药系统中,并成为肿瘤治疗研究的热点。本文主要对HA在新型给药系统的应用进行介绍。Due to the good physical and chemical properties and tumor targeting ability, hyaluronic acid （HA） has been used as drug carriers or targeting ligand in the novel drug delivery system for cancer therapy, and become the new hot point in the field of cancer therapy. This review mainly introduced the application of HA in the novel drug delivery system.

关 键 词：透明质酸 肿瘤靶向 纳米粒 胶束 脂质体 自组装复合物 

分 类 号：R730.5[医药卫生—肿瘤] R979.1[医药卫生—临床医学]